what is known already: PCOS is a heterogeneous endocrinopathy characterized by oligo-anovulation, hyperandrogenism and polycystic ovaries. In a previous genome-wide association study, the SNP variants rs13429458, rs12478601, rs2479106, rs10818854 and rs13405728 in the THADA, DENND1A and LHCGR genes were identified as being independently associated with PCOS. The aim of this study was to identify any additional correlations between the phenotypes of PCOS and genotypes of the five SNPs described in the previous study. study design, size, duration: In the present cross-sectional study, a total of 1731 PCOS patients and 4964 controls were enrolled.
Introduction
Polycystic ovary syndrome (PCOS) is a common endocrinopathy with a prevalence ranging from 6 to 8% in women of reproductive age (Azziz et al., 2004) . It is characterized by hyperandrogenism (HA), menstrual irregularity and polycystic ovarian morphology, and commonly leads to anovulatory infertility and metabolic complications, including metabolic syndrome, type 2 diabetes (T2D) and cardiovascular disease (CVD; Legro et al., 2005; de Groot et al., 2011) . PCOS is a multifactorial disease caused by complex interactions between environmental factors and predisposing polygenic backgrounds (Vink et al., 2006) . However, the heterogeneity and uncertain etiology of PCOS have made it difficult to identify candidate genes.
Genome-wide association studies (GWASs) offer a potentially powerful approach to identify the associations between millions of single nucleotide polymorphisms (SNPs) and specific traits or disorders (Hirschhorn and Daly, 2005) . Our first GWAS in a Han Chinese cohort revealed three novel susceptibility loci for PCOS, based on the Rotterdam criteria, on chromosomes 2p16.3 (rs13405728), 2p21 (rs13429458, rs12478601) and 9q33.3 (rs10818854, rs2479106). The associated linkage disequilibrium (LD) blocks contained the susceptibility genes LHCGR, THADA and DENND1A, respectively (Chen et al., 2011) , which were partially confirmed in some recent studies in European cohorts (Lerchbaum et al., 2011; Eriksen et al., 2012; Goodarzi et al., 2012; Welt et al., 2012) . The LHCGR gene, which is located on chromosome 2p16.3, encodes the luteinizing hormone/choriogonadotropin receptor (LHCGR) belonging to the family of G-protein coupled receptors (Atger et al., 1995) . It is expressed in a variety of tissues, including the ovary, testis and several other non-gonadal tissues (Rahman and Rao, 2009 ). The thyroid adenoma-associated gene (THADA), mapping to chromosome 2p21, was first identified as a target gene in thyroid benign tumors (Rippe et al., 2003) . A recent GWAS reported that THADA is a novel T2D-associated gene that affects pancreatic beta-cell function (Zeggini et al., 2008) . DENND1A is located on chromosome 9q33.3 and encodes a domain of DENN, which is differentially expressed in normal and neoplastic cells and functions as a guanine nucleotide exchange factor for the early endosomal small GTPase Rab35 (Marat and McPherson, 2010 (Yilmaz et al., 2011; Panidis et al., 2012) . However, the influence of the susceptibility SNPs identified in the previous GWAS on the specific subtypes and their associations with endocrine and metabolic characteristics remain unknown.
In this study, clinical data of the patients tested in the first GWAS were collected to identify correlations between their genotypes and phenotypes. Key features, including endocrine and metabolic parameters, were analyzed to determine their potential genetic associations.
Materials and Methods

Subjects
The study cohort consisted of 1731 PCOS patients with complete clinical data. Participants originated from our first GWAS and were recruited at the reproductive medical center of Shandong Provincial Hospital affiliated to Shandong University. All of them were unrelated individuals of reproductive age with no hormonal therapy for at least three months prior to the test.
The diagnosis of PCOS was based on the Rotterdam Consensus proposed in 2003 (Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004). OA was determined by a menstrual cycle more than 35 days in length or a history of ≤8 menstrual cycles in a year (Azziz et al., 2004) . Polycystic ovarian (PCO) morphology was determined when ≥12 follicles measuring 2 -9 mm in diameter were scanned in one or both ovaries or the ovarian volume was above 10 ml. HA was confirmed if there was evidence of hyperandrogenemia and/or hirsutism. Patients were grouped according to the four subtypes introduced in the revised consensus of Rotterdam (described in Table I ). The diagnosis of PCOS was made only when the other etiologies for hyperandrogenemia and ovulatory dysfunction were excluded, i.e. congenital adrenal Genotype -phenotype correlations in PCOS hyperplasias, 21-hydroxylase deficiency, androgen-secreting tumors, Cushing's syndrome, thyroid disease and hyperprolactinemia (Chen et al., 2011) .
A total of 4964 age-matched healthy women who were referred for routine physical examination or tubal factor infertility were enrolled. All subjects in the control group had regular menstrual cycles (26-35 days) and normal ovarian morphology (antral follicle counts ,12 in each ovary). Total testosterone levels and hirsutism scores were also evaluated for exclusion of HA.
The study was approved by the Institutional Review Board of Reproductive Medicine of Shandong University and written informed consent was obtained from all participants.
Clinical and biochemical measurements
Medical-history and anthropometric data (height, weight) were obtained from PCOS patients during a visit to the clinic. All patients underwent transvaginal ultrasound scanning for PCO and modified FerrimanGallwey scoring for the identification of hirsutism (Hatch et al., 1981) . Subjects were deemed hirsute if the score was six or higher (Ferriman and Gallwey, 1961) . The body mass index (BMI) was calculated using the following formula: weight (kg)/height (m) 2 . After an overnight fast, blood sampling was performed during the early follicular phase (between 2 and 5 days of the menstrual cycle) for the detection of hormones including follicular-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (T) and prolactin (PRL) by chemiluminescence immunoassays, all with intra-and inter-assay coefficients of variation ,10%. Hyperandrogenemia was defined as a serum total testosterone above 60 ng/dl (Shi et al., 2007) .
Each subject underwent a 75-g oral glucose tolerance test (OGTT). Plasma glucose levels at 0 min and 2 h after OGTT were measured using the oxidase method and insulin levels were measured by chemiluminescence immunoassays. The homeostasis model assessment (HOMA) of insulin resistance was derived by the calculation: fasting plasma glucose (mmol/l) * fasting insulin (mIU/ml)/22.5 (Matthews et al., 1985) .
Serum cholesterol (CHOL), triglycerides (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) were evaluated in fasting blood samples using the precipitation and enzymatic methods.
SNP determination
Determination of gene variants in THADA (rs13429458, rs12478601), DENND1A (rs2479106, rs10818854) and LHCGR (rs13405728) was performed according to the previous literature regarding PCOS susceptibility loci (Chen et al., 2011) .
Genomic DNA extraction was performed by a standard process using Flexi Gene DNA kits (Qiagen). The five SNPs selected were analyzed in genome-wide genotyping using the Affymetrix Genome-Wide Human SNP Array 6.0 and replicated using the ligation detection reaction in our previous GWAS. The success rate of genotyping for all SNPs was above 96%, and the genotype distributions obeyed Hardy -Weinberg equilibrium.
Statistical analysis
The allele frequency and genotype differences were calculated by PLINK (v.1.05, http://pngu.mgh.harvard.edu/purcell/plink). The case -control genetic power was calculated by Genetic Power Calculator (http://pngu .mgh.harvard.edu/~purcell/gpc/). A Bonferroni corrected P-value of 0.003 (15 tests in total) was set as the threshold in association with tests of genetic models. Clinical data analysis was performed using Statistical Package for the Social Sciences for Windows (version 13.0; SPSS Inc., Chicago, IL, USA). Considering the small numbers in the homozygous minor allele groups, an appropriate genetic model was adopted for each SNP and the Mann-Whitney test was used to determine any significant differences for between-group comparisons, with data presented as the median (and the interquartile range) because the distribution remained non-normal even after log or square root transformation. Analysis of covariance was used for age and BMI adjustment. A P-value ,0.05 was considered statistically significant in genotype -phenotype analyses.
Results
The clinical features of the PCOS cohort are shown in Supplementary data, Table SI . A total of 1731 PCOS subjects, a subgroup of patients in our first GWAS, were enrolled due to the availability of detailed clinical data. The average age of the subjects was 28 years, with a mean BMI of 24.46 kg/m 2 . A total of 631 patients presented with Subtype A (36.5%), 271 patients presented with Subtype B (15.7%), 212 patients presented with Subtype C (12.2%) and 617 patients presented with Subtype D (35.6%; Table I ). Associations between the rs13429458, rs12478601, rs2479106, rs10818854 and rs13405728 variants and PCOS identified in the previous GWAS were verified in the present cohort (Supplementary data, Table SII ; Lerchbaum et al., 2011) . The allele frequencies of the five SNPs in the different sub-phenotypic groups are presented in Table II . The rs13429458 SNP was associated with all four subtypes (P ¼ 1.00E203, P ¼ 1.30E203, P ¼ 5.00E203 and P ¼ 1.75E205, respectively). For rs12478601, rs2479106 and rs10818854, statistically significant differences were found for Subtypes A (P ¼ 5.78E206, P ¼ 9.08E205 and P ¼ 1.68E206), B (P ¼ 9.00E204, P ¼ 2.67E202 and P ¼ 1.29E202) and D (P ¼ 1.80E207, P ¼ 3.60E203 and P ¼ 6.67E205). For rs13405728, there was a significant association with Subtype A (P ¼ 5.00E204), C (P ¼ 2.00E204) and D (P ¼ 2.00E204).
The genetic models of the five SNPs were analyzed (Supplementary data, Table SIII ) and significant differences were observed for the additive and dominant models. Associations were also identified for the recessive models of rs13429458, rs12478601 and rs13405728. Given that statistical power could be limited by a small number of homozygous minor alleles and thus result in false-positive relationships, the additive model was not taken into account. Further genotype-phenotype correlation analyses were performed using the recessive models of rs13429458, rs12478601 and rs13405728, and the dominant models of rs2479106 and rs10818854, which were proved to be more significant than the other two models (dominant and recessive; Lerchbaum et al., 2011; Simonis-Bik et al., 2010) . All tested powers of selected models were calculated by the Genetic Power Calculator and reached 0.8 at P ¼ 0.001.
rs13429458 (THADA)
Using a recessive model, patients with the AA genotype of rs13429458 were older and had higher serum LH and T levels than the patients with the AC and CC genotypes (P ¼ 0.02 and P ¼ 0.03, respectively; Table III ). The LH/FSH ratio was also higher in the patients with the AA genotype (P ¼ 0.02; Table III ). The statistical significance was independent of age and BMI (P , 0.01, P ¼ 0.02 and P , 0.01, respectively, after adjusting for age and BMI).
rs12478601 (THADA)
Using a recessive model for rs12478601, the average age of the subjects with PCOS with the CC genotype were significantly higher (P ¼ 0.01; Table IV), and these patients had elevated serum LDL levels (P ¼ 0.02; ), body mass index; mFG, modified Ferriman -Gallwey hirsutism score; FSH (IU/l), follicle-stimulating hormone; LH (IU/l), luteinizing hormone; PRL (ng/ dl), prolactin; T (ng/dl), testosterone; Glucose (mmol/l); Insulin (mIU/ml); HOMA, homeostasis model assessment; CHOL (mmol/l), cholesterol; TG (mmol/l), triglyceride; LDL (mmol/l), low-density lipoprotein; HDL (mmol/l), high-density lipoprotein. Genotype -phenotype correlations in PCOS the subjects with the CC genotype after adjusting for age and BMI (P ¼ 0.02).
rs2479106 (DENND1A)
Compared with the non-risk group, the GG + AG group showed increased levels of insulin 2 h after a 75-g glucose load, when using the dominant model for rs2479106 (P ¼ 0.02; Table V ). The difference remained statistically significant after adjusting for age and BMI (P ¼ 0.02).
rs10818854 (DENND1A)
Using a dominant model, the different genotype groups for rs10818854 did not show any significant differences in phenotype (Supplementary data, Table SIV ).
rs13405728 (LHCGR)
Although a lower fasting insulin level and HOMA were observed in patients with the AA genotype at rs13405728 using a recessive model (Supplementary data, Table SV), no significant differences were found after adjusting for age and BMI (P ¼ 0.23 and P ¼ 0.19, respectively).
Discussion
Five susceptibility SNPs of PCOS had been identified in the previous GWAS of a Han Chinese cohort, suggesting the clinical relevance of several novel candidate genes, including THADA, DENND1A and LHCGR. In the present study, correlations between the risk genotypes and the clinical characteristics were analyzed in a subgroup of the PCOS patients tested in the GWAS.
Using genotype -phenotype correlation analysis, the five susceptibility SNPs appear to have different contributions to each subtype. The SNPs in THADA and DENND1A were associated with specific subtypes including PCO, whereas LHCGR (rs13405728) may be more likely to contribute to the subtype in patients with oligo-or anovulation. The correlation analysis implicates different genetic backgrounds that have the potential to influence specific subtypes, and provides genetic support to the diagnosis of PCOS. However, additional studies on a larger scale are needed to confirm this hypothesis because the number of patients evaluated in several of the subphenotype groups was low, which may weaken the statistical power.
Subsequent quantitative trait analysis revealed an association between the rs13429458 AA genotype in the THADA gene and increased levels of T. As a key pathophysiological feature of PCOS, hyperandrogenemia significantly affects the progression of the ), body mass index; WHR, waist to hip ratio; mFG, modified FerrimanGallwey hirsutism score; FSH (IU/l), follicle-stimulating hormone; LH (IU/l), luteinizing hormone; PRL (ng/dl), prolactin; T (ng/dl), testosterone; Glucose (mmol/l); Insulin(mIU/ml); HOMA, homeostasis model assessment; CHOL (mmol/l), cholesterol; TG(mmol/l), triglyceride; LDL (mmol/l), low-density lipoprotein; HDL (mmol/l), high-density lipoprotein. syndrome. It has been implied that excess androgen accelerates early follicle development and reduces the atresia rate of early antral follicles, which could induce polycystic changes in the ovary (Gleicher et al., 2011) Moreover, the polymorphism at rs13429458 was also identified to be associated with subtypes involving HA, which further indicated that the THADA gene possibly supports androgen excess in PCOS. Considering the low prevalence of HA in East Asian women, it is preferable to replicate these findings in a Caucasian population, which is more hirsute in general.
Additionally, individuals with the rs13429458 AA genotype had higher LH concentrations, which could persistently stimulate the ovarian theca cell and result in an overproduction of androgen in the gonadotrophin-dependent stages of folliculogenesis (Dumesic and Abbott, 2008) . Hypersecretion of LH in patients with PCOS has been shown to be related to anovulation due to the aberrant expression of the receptor, increased LH/FSH values and the absence of the LH peak (Zhu et al., 2010) . Furthermore, the significant association between the SNP at rs13429458 and PCOS subtypes with OA also suggested that there might be a contribution of THADA to anovulation in PCOS.
The rs12478601 SNP is independently located in the THADA gene and was identified in the previous GWAS. In the current study, elevated LDL concentrations in the subgroup with the CC genotype demonstrate the association between the SNP in THADA and dyslipidemia for the first time. Because increased LDL levels are an important component of metabolic syndrome and an independent risk factor of CVD, these results suggest that patients with the CC genotype have the potential for developing hyperlipemia and additional severe complications.
Using a dominant model, in the GG + GA group for rs2479106 in the DENNDIA gene, the 2 h insulin levels after OGTT were significantly higher, suggesting that patients with these genotypes have an increased risk of insulin resistance. Insulin resistance and compensatory hyperinsulinemia are recognized as causes of hyperandrogenemia and, more importantly, can lead to T2D, hypertension and CVD, which are longterm complications of PCOS (Saad et al., 1991; Mather et al., 2000) .
No associations were observed between the rs10818854 genotype in DENND1A and the key features of PCOS. These results may be due to the younger age of the patients in the study, as potential associations may become more significant over time. Additional research is necessary to test this hypothesis.
A previous study of 545 Caucasian women with PCOS reported that the rs13405728 genotype was associated with glucose and insulin metabolism, which was not observed in our study (Lerchbaum et al., 2011) . The conflicting results may be due to differences in genetic backgrounds and environmental factors in the Chinese and Caucasian populations. The relatively young age of the subjects in this study may be an additional influential factor.
Notably, the increased type I error caused by multiple tests is often rectified by the Bonferroni correction. In the present study, the corrected P value should be 0.003(0.05/17), considering the 17 parameters involved. Compared with the corrected P-value, the significance that emerged cannot be regarded as statistically relevant. However, since the Bonferroni correction is considered too conservative when the tests are done more than 10 times (Moran, 2003) , it is not reasonable to deny the associations of the three SNPs in the THADA and DENND1A genes and the pathophysiological characteristics such as increased levels of LH, T, LDL or insulin. The results, to some extent, indicate the increased risk in patients with a risk allele, and should be replicated in a large population from different ethnic groups.
In addition, there are several limitations to the present study. First, the low average age of the participants may represent a considerable bias when evaluating endocrine alterations as a function of different genotypes, and significant endocrine and metabolic disturbances may emerge later in life. Secondly, the sample size in several sub-genotype groups was low (e.g. rs13405728 GG genotype, rs13429458 CC genotype and rs10818854 AA genotype), which limited the statistical power of the analysis. Thus, as a compromised method, the genetic models were adopted under the current circumstance and provided a preliminary indication for genotype -phenotype associations. Validation on a larger scale is expected in the future. Thirdly, although the phenotypic variations identified between the sub-genotype groups were moderate, they are consistent with the probable small contribution of individual risk alleles in a multigenic complex disorder.
The associations observed in the present study suggest a higher risk of exhibiting several of the key pathophysiological characteristics of PCOS, including hypersecretion of LH and T, which is crucial for anovulation, and dyslipdemia and hyperinsulinemia, which can be a sign of metabolic disturbances and an underlying increased risk of long-term complications. The results provide inspiration for further functional studies and may help identify individuals who are more likely to respond to targeted therapies. The differences between the subgenotype groups indicate an increased risk in the patients with specific risk alleles. To our knowledge, this is the first study in a Han Chinese population with PCOS to report genotype -phenotype correlations in the THADA and DENND1A genes. Replication of the study in larger cohorts of patients with various genetic backgrounds should be pursued. Additional studies regarding gene functions will be required to gain substantial insights into the etiological mechanisms of the effect of these genes on PCOS phenotypes.
In conclusion, the various phenotypes of PCOS may be due to differences in genetic backgrounds. Based on the data collected from a large cohort of PCOS patients, the THADA gene contributes to lipid metabolic disorders and hypersecretion of T and LH, while the DENND1A gene is partially responsible for insulin resistance in PCOS patients.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
